143 related articles for article (PubMed ID: 27768597)
1. Celastrol increases osteosarcoma cell lysis by γδ T cells through up-regulation of death receptors.
Li Z; Zhang J; Tang J; Wang R
Oncotarget; 2016 Dec; 7(51):84388-84397. PubMed ID: 27768597
[TBL] [Abstract][Full Text] [Related]
2. [Effect of zoledronate on the cytotoxicity of γδ T cells from PBMCs of osteosarcoma patients against osteosarcoma].
Li Z; Tang J; Sun L; Ye Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):6-9. PubMed ID: 23294710
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ enhances HOS and U2OS cell lines susceptibility to γδ T cell-mediated killing through the Fas/Fas ligand pathway.
Li Z; Xu Q; Peng H; Cheng R; Sun Z; Ye Z
Int Immunopharmacol; 2011 Apr; 11(4):496-503. PubMed ID: 21238618
[TBL] [Abstract][Full Text] [Related]
4. Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells
Wang Z; Wang Z; Li S; Li B; Sun L; Li H; Lin P; Wang S; Teng W; Zhou X; Ye Z
Front Immunol; 2018; 9():1239. PubMed ID: 29910819
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.
Zhu H; Liu XW; Ding WJ; Xu DQ; Zhao YC; Lu W; He QJ; Yang B
Cancer Lett; 2010 Nov; 297(2):155-64. PubMed ID: 20605676
[TBL] [Abstract][Full Text] [Related]
6. TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.
Tawfik D; Groth C; Gundlach JP; Peipp M; Kabelitz D; Becker T; Oberg HH; Trauzold A; Wesch D
Front Immunol; 2019; 10():2044. PubMed ID: 31555275
[TBL] [Abstract][Full Text] [Related]
7. [Interferon-γ enhances human γδ T cell-mediated osteosarcoma cell killing in vitro].
Li Z; Tang J; Ye Z
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):22-5. PubMed ID: 23353149
[TBL] [Abstract][Full Text] [Related]
8. NKG2D regulates production of soluble TRAIL by ex vivo expanded human γδ T cells.
Dokouhaki P; Schuh NW; Joe B; Allen CA; Der SD; Tsao MS; Zhang L
Eur J Immunol; 2013 Dec; 43(12):3175-82. PubMed ID: 24019170
[TBL] [Abstract][Full Text] [Related]
9. [Amplification of γδ T cells in PBMCs of healthy donors and osteosarcoma patients stimulated by zoledronate].
Li ZX; Sun LL; Cheng RL; Sun ZW; Ye ZM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):822-4. PubMed ID: 22863589
[TBL] [Abstract][Full Text] [Related]
10. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
[TBL] [Abstract][Full Text] [Related]
11. Effect and mechanisms of celastrol on the apoptosis of HOS osteosarcoma cells.
Chen Y; Ou Y; Tao Y; Liu H; Yin H; Zhong S; Yu H; Zhao Z; He B
Oncol Rep; 2018 Oct; 40(4):2260-2268. PubMed ID: 30106429
[TBL] [Abstract][Full Text] [Related]
12. Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma.
Fowler D; Barisa M; Southern A; Nattress C; Hawkins E; Vassalou E; Kanouta A; Counsell J; Rota E; Vlckova P; Draper B; De Mooij T; Farkas A; Brezovjakova H; Baker AT; Scotlandi K; Manara MC; Tape C; Chester K; Anderson J; Fisher J
Sci Transl Med; 2024 May; 16(749):eadg9814. PubMed ID: 38809963
[TBL] [Abstract][Full Text] [Related]
13. Potential of human γδ T cells for immunotherapy of osteosarcoma.
Li Z
Mol Biol Rep; 2013 Jan; 40(1):427-37. PubMed ID: 23065272
[TBL] [Abstract][Full Text] [Related]
14. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT
Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278
[TBL] [Abstract][Full Text] [Related]
15. CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.
Knight A; Arnouk H; Britt W; Gillespie GY; Cloud GA; Harkins L; Su Y; Lowdell MW; Lamb LS
PLoS One; 2013; 8(8):e68729. PubMed ID: 23950874
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Ex Vivo Expanded γδ T Cells against Osteosarcoma Cells.
Ko Y; Jeong YH; Lee JA
Cells; 2022 Jul; 11(14):. PubMed ID: 35883606
[TBL] [Abstract][Full Text] [Related]
17. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
Guo BL; Liu Z; Aldrich WA; Lopez RD
Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
[TBL] [Abstract][Full Text] [Related]
18. Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells.
Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T
J Orthop Res; 2010 Jun; 28(6):739-45. PubMed ID: 20041491
[TBL] [Abstract][Full Text] [Related]
19. In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice.
Hodgins NO; Al-Jamal WT; Wang JT; Parente-Pereira AC; Liu M; Maher J; Al-Jamal KT
J Control Release; 2016 Nov; 241():229-241. PubMed ID: 27664328
[TBL] [Abstract][Full Text] [Related]
20. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M
Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
